Impact of multi-level factors and partner characteristics on antiretroviral therapy adherence and access to HIV care during the COVID-19 pandemic
International Journal of STD & AIDS · 2025
DOI: 10.1177/09564624251329626 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of STD & AIDS, 2025. Verfasst von Paige Neuenschwander und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, State University of New York-Downstate Health Science University, Brooklyn, NY, USA. Hauptthemen laut MEDLINE: HIV Infections, COVID-19, Medication Adherence, Health Services Accessibility. Die Arbeit nennt 41 Literaturangaben. Gefördert von: NIDA NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
Adherence to antiretroviral therapy (ART) remains a challenge for many people with HIV and was exacerbated during the COVID-19 pandemic. This paper examines factors associated with ART adherence among people with HIV who inject drugs (PWHWID) in Almaty, Kazakhstan during the COVID-19 pandemic.
Methods
A cross-sectional survey was conducted from October 2020 to August 2022 with 66 PWHWID and their treatment support partners ( n = 66) to assess associations between ART adherence and sociodemographic, COVID-19 related, social support, and other factors. Multilevel generalized linear mixed models were used to examine factors associated with optimal (≥90%) and standard (≥80%) adherence levels.
Results
We found low medication adherence rates: only 55.8% took ≥80% of their doses, and just 14.7% took ≥90%. People were more likely to take their medication consistently if they had a partner with HIV, experienced less household conflict during COVID-19, or met with addiction professionals. Poor mental health and negative emotional impacts from COVID-19 were associated with low adherence.
Conclusion
These findings suggest that HIV treatment programs should consider the importance of patients’ relationship factors, mental health, and home environment impacts during public health crises.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, State University of New York-Downstate Health Science University, Brooklyn, NY, USA.
- Section of Infectious Diseases, Department of Medicine, Yale University, New Haven, CT, USA.
- Division of Gender, Sexuality & Health, HIV Center, New York State Psychiatric Institute and Columbia University Irving Medical Center, New York, NY, USA.
- Global Health Research Center of Central Asia, Almaty, Kazakhstan.
- School of Social Work, Columbia University, New York, NY, USA.
ORCID-Profile: Paige Neuenschwander
Förderung
- NIDA NIH HHS
- National Institutes of Health
Zitieren
APA
Neuenschwander, P., Norcini Pala, A., Altice, F. L., Remien, R. H., Mergenova, G., Rozental, E., Gulyayev, V., & Davis, A. (2025). Impact of multi-level factors and partner characteristics on antiretroviral therapy adherence and access to HIV care during the COVID-19 pandemic. International Journal of STD & AIDS. https://doi.org/10.1177/09564624251329626
Vancouver
Neuenschwander P, Norcini Pala A, Altice FL, Remien RH, Mergenova G, Rozental E, et al. Impact of multi-level factors and partner characteristics on antiretroviral therapy adherence and access to HIV care during the COVID-19 pandemic. International Journal of STD & AIDS. 2025. doi:10.1177/09564624251329626
BibTeX
@article{Neuenschwander2025,
author = {Neuenschwander, Paige and Norcini Pala, Andrea and Altice, Fredrick L and Remien, Robert H and Mergenova, Gaukhar and Rozental, Elena and Gulyayev, Valeriy and Davis, Alissa},
title = {Impact of multi-level factors and partner characteristics on antiretroviral therapy adherence and access to HIV care during the COVID-19 pandemic},
journal = {International Journal of STD & AIDS},
year = {2025},
doi = {10.1177/09564624251329626}
}
EUVIMED